4.4 Article

The return of individual genomic results to research participants: design and pilot study of Tohoku Medical Megabank Project

Journal

JOURNAL OF HUMAN GENETICS
Volume 67, Issue 1, Pages 9-17

Publisher

SPRINGERNATURE
DOI: 10.1038/s10038-021-00952-8

Keywords

-

Funding

  1. Tohoku Medical Megabank Project of Ministry of Education, Culture, Sports, Science and Technology (MEXT)
  2. AMED [JP 19km0105001, JP 19km0105002, JP 19km0105003, JP 19km0105004]

Ask authors/readers for more resources

Large genome cohort studies are exploring the return of individual genomic results to participants, with a focus on addressing challenges through multilayer pilot studies targeting different diseases/genes. The first pilot study selected familial hypercholesterolemia, successfully disclosing results and guiding positive participants to medical care through educational genetics workshops and involvement of genetics professionals.
Certain large genome cohort studies attempt to return the individual genomic results to the participants; however, the implementation process and psychosocial impacts remain largely unknown. The Tohoku Medical Megabank Project has conducted large genome cohort studies of general residents. To implement the disclosure of individual genomic results, we extracted the potential challenges and obstacles. Major challenges include the determination of genes/disorders based on the current medical system in Japan, the storage of results, prevention of misunderstanding, and collaboration of medical professionals. To overcome these challenges, we plan to conduct multilayer pilot studies, which deal with different disorders/genes. We finally chose familial hypercholesterolemia (FH) as a target disease for the first pilot study. Of the 665 eligible candidates, 33.5% were interested in the pilot study and provided consent after an educational genetics workshop on the basic genetics and medical facts of FH. The genetics professionals disclosed the results to the participants. All positive participants were referred to medical care, and a serial questionnaire revealed no significant psychosocial distress after the disclosure. Return of genomic results to research participants was implemented using a well-prepared protocol. To further elucidate the impact of different disorders, we will perform multilayer pilot studies with different disorders, including actionable pharmacogenomics and hereditary tumor syndromes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available